1. Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects. Issue 4 (22nd November 2021) Authors: Becker, Anna M.; Holze, Friederike; Grandinetti, Tanja; Klaiber, Aaron; Toedtli, Vanja E.; Kolaczynska, Karolina E.; Duthaler, Urs; Varghese, Nimmy; Eckert, Anne; Grünblatt, Edna; Liechti, Matthias E. Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 4(2022) Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. Issue 5 (February 2018) Authors: Liakoni, Evangelia; Yates, Christopher; Dines, Alison M.; Dargan, Paul I.; Heyerdahl, Fridtjof; Hovda, Knut Erik; Wood, David M.; Eyer, Florian; Liechti, Matthias E. Other Names: Czarnik. Tomasz section editor. Journal: Medicine Issue: Volume 97:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chiral analysis of amphetamines in hair by liquid chromatography–tandem mass spectrometry: compliance‐monitoring of attention deficit hyperactivity disorder (ADHD) patients under Elvanse® therapy and identification after controlled low‐dose application. Issue 2 (5th July 2017) Authors: Binz, Tina M.; Williner, Elena; Strajhar, Petra; Dolder, Patrick C.; Liechti, Matthias E.; Baumgartner, Markus R.; Kraemer, Thomas; Steuer, Andrea E. Journal: Drug testing and analysis Issue: Volume 10:Issue 2(2018) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs. (8th April 2022) Authors: Heier, Eva-Carina; Eyer, Florian; Rabe, Christian; Geith, Stefanie; Dargan, Paul I.; Wood, David M.; Heyerdahl, Fridtjof; Dines, Alison M.; Giraudon, Isabelle; Erik Hovda, Knut; Yates, Chris; Vallersnes, Odd Martin; Miró, Òscar; Liechti, Matthias E.; Zellner, Tobias Other Names: Anand Lukasz author non-byline.; Waldman Wojciech author non-byline.; Anseeuw Kurt author non-byline.; Gillebeert Johan author non-byline.; Badaras Robertas author non-byline.; Laubner, Gabija author non-byline.; Bonnici, Jeffrey author non-byline.; Brvar Miran author non-byline.; Grenc, Damjan a... Journal: European journal of emergency medicine Issue: Volume 29:Number 4(2022) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication. Issue 3 (17th December 2019) Authors: Grafinger, Katharina Elisabeth; Liechti, Matthias E.; Liakoni, Evangelia Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 3(2020) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3, 4-methylene-dioxymethamphetamine in a controlled study in healthy individuals. Issue 8 (August 2016) Authors: Schmid, Yasmin; Vizeli, Patrick; Hysek, Cédric M.; Prestin, Katharina; Meyer zu Schwabedissen, Henriette E.; Liechti, Matthias E. Journal: Pharmaocogenetics and genomics Issue: Volume 26:Issue 8(2016:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and validation of an LC‐MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy‐methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma. Issue 7 (4th November 2014) Authors: Steuer, Andrea E.; Schmidhauser, Corina; Liechti, Matthias E.; Kraemer, Thomas Journal: Drug testing and analysis Issue: Volume 7:Issue 7(2015:Jul.) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development and validation of an LC‐MS/MS method to quantify lysergic acid diethylamide (LSD), iso‐LSD, 2‐oxo‐3‐hydroxy‐LSD, and nor‐LSD and identify novel metabolites in plasma samples in a controlled clinical trial. Issue 2 (26th May 2017) Authors: Dolder, Patrick C.; Liechti, Matthias E.; Rentsch, Katharina M. Journal: Journal of clinical laboratory analysis Issue: Volume 32:Issue 2(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development and validation of an ultra‐fast and sensitive microflow liquid chromatography‐tandem mass spectrometry (MFLC‐MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans. Issue 5 (10th August 2016) Authors: Steuer, Andrea E.; Poetzsch, Michael; Stock, Lorena; Eisenbeiss, Lisa; Schmid, Yasmin; Liechti, Matthias E.; Kraemer, Thomas Journal: Drug testing and analysis Issue: Volume 9:Issue 5(2017) Page Start: 788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development of a high‐speed MALDI‐triple quadrupole mass spectrometric method for the determination of 3, 4‐methylenedioxymethamphetamine (MDMA) in oral fluid. Issue 2 (19th May 2015) Authors: Poetzsch, Michael; Steuer, Andrea E.; Hysek, Cedric M.; Liechti, Matthias E.; Kraemer, Thomas Journal: Drug testing and analysis Issue: Volume 8:Issue 2(2016:Feb.) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗